Avanir Pharmaceuticals About
Avanir Pharmaceuticals: AVANIR PHARMACEUTICALS is a publicly
held California corporation (AVN) formed in 1988 and publicly traded since 1990.
The company was formed to develop and commercialize novel therapeutic products
for the treatment of chronic diseases. Avanir's first product, Abreva(R)
is a topical treatment for cold
sores. The company's lead product candidate is Neurodex(TM),
for the treatment of pseudobulbar affect (also known as emotional lability) in
neurodegenerative diseases. Other potential indications for this product include
neuropathic pain, chronic cough and weaning drug dependent patients from narcotics
and anti-depressants. Preclinical programs are currently ongoing in the
areas of atherosclerosis
and inflammation.
Other areas of development include their patented fully human monoclonal antibody
technology. Pipeline:
Key
Statistics fo
Avanir
Neurodex Pseudobulbar
Affect Neurodex Neuropathic
Pain
Avanir Asthma
More on Avanir Pharmaceuticals:
Basic Chart for
Avanir